Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Eva Ogorevc, Eva Shannon Schiffrer, Izidor Sosič & Stanislav Gobec. (2018) A patent review of immunoproteasome inhibitors. Expert Opinion on Therapeutic Patents 28:7, pages 517-540.
Read now
Read now
Helge L. Waldum. (2009) This month in the Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 44:8, pages 900-901.
Read now
Read now
Articles from other publishers (26)
Yuan Wang, Simon Jasinski-Bergner, Claudia Wickenhauser & Barbara Seliger. (2023) Cancer Immunology: Immune Escape of Tumors—Expression and Regulation of HLA Class I Molecules and Its Role in Immunotherapies. Advances in Anatomic Pathology 30:3, pages 148-159.
Crossref
Crossref
Paul Shafer, Lauren M. Kelly & Valentina Hoyos. (2022) Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects. Frontiers in Immunology 13.
Crossref
Crossref
Ryan J. King, Fang Qiu, Fang Yu & Pankaj K. Singh. (2021) Metabolic and Immunological Subtypes of Esophageal Cancer Reveal Potential Therapeutic Opportunities. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Karthik Dhatchinamoorthy, Jeff D. Colbert & Kenneth L. Rock. (2021) Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation. Frontiers in Immunology 12.
Crossref
Crossref
Kateryna Nesteruk, Vincent T. Janmaat, Hui Liu, Timo L.M. Ten Hagen, Maikel P. Peppelenbosch & Gwenny M. Fuhler. (2020) Forced expression of HOXA13 confers oncogenic hallmarks to esophageal keratinocytes. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866:8, pages 165776.
Crossref
Crossref
Fang-Fang Shen, Ying Pan, Jing-Zhong Li, Fang Zhao, Hai-Jun Yang, Jun-Kuo Li, Zhao-Wei Gao, Jing-Fen Su, Li-Juan Duan, Shu-Min Lun, Peng Zhang, Lin-Qiang Tian, Gang Sun, Da Huang, Yan-Tian Cao & Fu-You Zhou. (2019) High expression of HLA-DQA1 predicts poor outcome in patients with esophageal squamous cell carcinoma in Northern China. Medicine 98:8, pages e14454.
Crossref
Crossref
Nathalie Vigneron, Violette Ferrari, Benoît J. Van den Eynde, Peter Cresswell & Ralf M. Leonhardt. (2018) Cytosolic Processing Governs TAP-Independent Presentation of a Critical Melanoma Antigen. The Journal of Immunology 201:7, pages 1875-1888.
Crossref
Crossref
David Vrana, Viktor Hlavac, Veronika Brynychova, Radka Vaclavikova, Cestmir Neoral, Jiri Vrba, Rene Aujesky, Marcel Matzenauer, Bohuslav Melichar & Pavel Soucek. (2018) ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer. International Journal of Molecular Sciences 19:3, pages 868.
Crossref
Crossref
Mayinuer Alifu, Yun-Hui Hu, Tao Dong & Ruo-Zheng Wang. (2018) HLA-A*30. Journal of Cancer Research and Therapeutics 14:6, pages 1266-1272.
Crossref
Crossref
Douglas F. Lake. 2017. Peptidomics of Cancer-Derived Enzyme Products. Peptidomics of Cancer-Derived Enzyme Products
81
103
.
Fernando Concha-Benavente, Raghvendra Srivastava, Soldano Ferrone & Robert L. Ferris. (2016) Immunological and clinical significance of HLA class I antigen processing machinery component defects in malignant cells. Oral Oncology 58, pages 52-58.
Crossref
Crossref
Ningjing Zou, Lan Yang, Ling Chen, Tingting Li, Tingting Jin, Hao Peng, Shumao Zhang, Dandan Wang, Ranran Li, Chunxia Liu, Jinfang Jiang, Lianghai Wang, Weihua Liang, Jianming Hu, Shugang Li, Chuanyue Wu, Xiaobin Cui, Yunzhao Chen & Feng Li. (2015) Heterozygote of TAP1 Codon637 decreases susceptibility to HPV infection but increases susceptibility to esophageal cancer among the Kazakh populations. Journal of Experimental & Clinical Cancer Research 34:1.
Crossref
Crossref
Ilyar Sheyhidin, Ayshamgul Hasim, Feng Zheng & Hong Ma. (2015) Epigenetic Changes within the Promoter Regions of Antigen Processing Machinery Family Genes in Kazakh Primary Esophageal Squamous Cell Carcinoma. Asian Pacific Journal of Cancer Prevention 15:23, pages 10299-10306.
Crossref
Crossref
Morgan A. O'Brien, Derek G. Power, A. James P. Clover, Brian Bird, Declan M. Soden & Patrick F. Forde. (2014) Local tumour ablative therapies: Opportunities for maximising immune engagement and activation. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1846:2, pages 510-523.
Crossref
Crossref
Hans Anton Schlößer, Sebastian Theurich, Alexander Shimabukuro-Vornhagen, Udo Holtick, Dirk Ludger Stippel & Michael von Bergwelt-Baildon. (2014) Overcoming tumor-mediated immunosuppression. Immunotherapy 6:9, pages 973-988.
Crossref
Crossref
Fang-Fang Shen, Wen-Bin Yue, Fu-You Zhou, Ying Pan, Xue-Ke Zhao, Yan Jin, Xin Song, Bei Li, Xue-Na Han, Sa Tang, Yan Li, Guo Yuan, Li-Sha Chen, Ya-Li Liu, Yan-Long Hu, Xiu-Min Li, Jing-Li Ren & Li-Dong Wang. (2014) Variations in the MHC Region Confer Risk to Esophageal Squamous Cell Carcinoma on the Subjects from High-Incidence Area in Northern China. PLoS ONE 9:3, pages e90438.
Crossref
Crossref
Biao Feng, Idiris Awuti, Yanchao Deng, Desheng Li, Maidiniyeti Niyazi, Julaiti Aniwar, Ilyar Sheyhidin, Guoqing Lu, Gang Li & Liwei Zhang. (2014) Human papillomavirus promotes esophageal squamous cell carcinoma by regulating DNA methylation and expression of HLA-DQB1. Asia-Pacific Journal of Clinical Oncology 10:1, pages 66-74.
Crossref
Crossref
YAN-XIN REN, JIE YANG, LI-JUAN ZHANG, RUI-MEI SUN, LIU-FANG ZHAO, MING ZHANG, YUN CHEN, JING MA, KUN QIAO, QIANG-MING SUN, HAI-TING LONG, YUN-CHAO HUANG & XIAO-JIANG LI. (2014) Downregulation of expression of transporters associated with antigen processing 1 and 2 and human leukocyte antigen I and its effect on immunity in nasopharyngeal carcinoma patients. Molecular and Clinical Oncology 2:1, pages 51-58.
Crossref
Crossref
Ji Eun Park, Lin Ao, Zachary Miller, Kyungbo Kim, Ying Wu, Eun Ryoung Jang, Eun Young Lee, Kyung Bo Kim & Wooin Lee. (2013) PSMB9 Codon 60 Polymorphisms Have No Impact on the Activity of the Immunoproteasome Catalytic Subunit B1i Expressed in Multiple Types of Solid Cancer. PLoS ONE 8:9, pages e73732.
Crossref
Crossref
P. Leone, E.-C. Shin, F. Perosa, A. Vacca, F. Dammacco & V. Racanelli. (2013) MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells. JNCI Journal of the National Cancer Institute 105:16, pages 1172-1187.
Crossref
Crossref
Feng Zheng, Ayshamgul Hasim, Juret Anwer, Madiniyet Niyaz & Ilyar Sheyhidin. (2013) LMP gene promoter hypermethylation is a mechanism for its down regulation in Kazak’s esophageal squamous cell carcinomas. Molecular Biology Reports 40:3, pages 2069-2075.
Crossref
Crossref
X. Zhang, A. Lin, J.-G. Zhang, W.-G. Bao, D.-P. Xu, Y.-Y. Ruan & W.-H. Yan. (2013) Alteration of HLA-F and HLA I antigen expression in the tumor is associated with survival in patients with esophageal squamous cell carcinoma. International Journal of Cancer 132:1, pages 82-89.
Crossref
Crossref
GENTARO ITO, HIROAKI TANAKA, MASAICHI OHIRA, MAMI YOSHII, KAZUYA MUGURUMA, NAOSHI KUBO, MASAKAZU YASHIRO, NOBUYA YAMADA, KIYOSHI MAEDA, TETSUJI SAWADA & KOSEI HIRAKAWA. (2012) Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I. Experimental and Therapeutic Medicine 3:6, pages 925-930.
Crossref
Crossref
KIMITAKA TANAKA, TAKAHIRO TSUCHIKAWA, MASAKI MIYAMOTO, TAKEHIRO MAKI, MASAOMI ICHINOKAWA, KANAKO C. KUBOTA, TOSHIAKI SHICHINOHE, SATOSHI HIRANO, SOLDANO FERRONE, HIROTOSHI DOSAKA-AKITA, YOSHIHIRO MATSUNO & SATOSHI KONDO. (2012) Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients. International Journal of Oncology 40:4, pages 965-974.
Crossref
Crossref
Z. Zhang, Y. Li, X. Guan, X. Yang, X. Yang, S. Li & X. Zou. (2012) Human leukocyte antigen class I on peripheral blood mononuclear cells as a non-invasive biomarker for esophageal cancer. Diseases of the Esophagus 25:3, pages 273-278.
Crossref
Crossref
Aifen Lin, Xia Zhang, Wen‐Jun Zhou, Yan‐Yun Ruan, Dan‐Ping Xu, Qing Wang & Wei‐Hua Yan. (2011) Human leukocyte antigen‐G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma. International Journal of Cancer 129:6, pages 1382-1390.
Crossref
Crossref